92 related articles for article (PubMed ID: 18236780)
21. Thermosensitive vaginal gel formulation for the controlled release of clotrimazole via complexation to beta-cyclodextrin.
Bilensoy E; Rouf MA; Vural I; Hincal AA
J Control Release; 2006 Nov; 116(2):e107-9. PubMed ID: 17718942
[No Abstract] [Full Text] [Related]
22. Pharmacokinetic evaluation in mice of amorphous itraconazole-based dry powder formulations for inhalation with high bioavailability and extended lung retention.
Duret C; Merlos R; Wauthoz N; Sebti T; Vanderbist F; Amighi K
Eur J Pharm Biopharm; 2014 Jan; 86(1):46-54. PubMed ID: 23523546
[TBL] [Abstract][Full Text] [Related]
23. Preparation, characterization, and evaluation of miconazole-cyclodextrin complexes for improved oral and topical delivery.
Tenjarla S; Puranajoti P; Kasina R; Mandal T
J Pharm Sci; 1998 Apr; 87(4):425-9. PubMed ID: 9548893
[TBL] [Abstract][Full Text] [Related]
24. Preclinical pharmacokinetic evaluation of resveratrol trimethyl ether in sprague-dawley rats: the impacts of aqueous solubility, dose escalation, food and repeated dosing on oral bioavailability.
Lin HS; Ho PC
J Pharm Sci; 2011 Oct; 100(10):4491-500. PubMed ID: 21520090
[TBL] [Abstract][Full Text] [Related]
25. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antifungal drug clotrimazole.
Ning M; Gu Z; Pan H; Yu H; Xiao K
Indian J Exp Biol; 2005 Feb; 43(2):150-7. PubMed ID: 15782815
[TBL] [Abstract][Full Text] [Related]
26. Novel formulation strategies for enhancing oral delivery of methoxyflavones in Kaempferia parviflora by SMEDDS or complexation with 2-hydroxypropyl-β-cyclodextrin.
Mekjaruskul C; Yang YT; Leed MG; Sadgrove MP; Jay M; Sripanidkulchai B
Int J Pharm; 2013 Mar; 445(1-2):1-11. PubMed ID: 23376503
[TBL] [Abstract][Full Text] [Related]
27. The influence of the preparation methods on the inclusion of model drugs in a beta-cyclodextrin cavity.
Salústio PJ; Feio G; Figueirinhas JL; Pinto JF; Cabral Marques HM
Eur J Pharm Biopharm; 2009 Feb; 71(2):377-86. PubMed ID: 18977436
[TBL] [Abstract][Full Text] [Related]
28. Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin.
Nair AB; Attimarad M; Al-Dhubiab BE; Wadhwa J; Harsha S; Ahmed M
Drug Deliv; 2014 Nov; 21(7):540-7. PubMed ID: 24215288
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of dissolution amount and in vivo bioavailability of itraconazole by complexation with beta-cyclodextrin using supercritical carbon dioxide.
Hassan HA; Al-Marzouqi AH; Jobe B; Hamza AA; Ramadan GA
J Pharm Biomed Anal; 2007 Oct; 45(2):243-50. PubMed ID: 17630246
[TBL] [Abstract][Full Text] [Related]
30. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
31. Nanoparticles formulation of Cuscuta chinensis prevents acetaminophen-induced hepatotoxicity in rats.
Yen FL; Wu TH; Lin LT; Cham TM; Lin CC
Food Chem Toxicol; 2008 May; 46(5):1771-7. PubMed ID: 18308443
[TBL] [Abstract][Full Text] [Related]
32. Enhanced oral absorption of saquinavir with Methyl-Beta-Cyclodextrin-Preparation and in vitro and in vivo evaluation.
Pathak SM; Musmade P; Dengle S; Karthik A; Bhat K; Udupa N
Eur J Pharm Sci; 2010 Nov; 41(3-4):440-51. PubMed ID: 20656025
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations.
Buchanan CM; Buchanan NL; Edgar KJ; Klein S; Little JL; Ramsey MG; Ruble KM; Wacher VJ; Wempe MF
J Pharm Sci; 2007 Nov; 96(11):3100-16. PubMed ID: 17712849
[TBL] [Abstract][Full Text] [Related]
34. Enhanced aqueous solubility and bioavailability of capsaicin by the preparation of an inclusion complex.
Chen X; Sun X; Ren K; Zhang X; Zhang Z; Gong T
Arzneimittelforschung; 2010; 60(9):571-4. PubMed ID: 21117501
[TBL] [Abstract][Full Text] [Related]
35. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Ranpise NS; Kulkarni NS; Mair PD; Ranade AN
Pharm Dev Technol; 2010; 15(1):64-70. PubMed ID: 19505225
[TBL] [Abstract][Full Text] [Related]
36. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
Desai C; Prabhakar B
Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
[TBL] [Abstract][Full Text] [Related]
37. Nano-encapsulation of azole antifungals: potential applications to improve oral drug delivery.
Pandey R; Ahmad Z; Sharma S; Khuller GK
Int J Pharm; 2005 Sep; 301(1-2):268-76. PubMed ID: 16023808
[TBL] [Abstract][Full Text] [Related]
38. Improvement of gliquidone hypoglycaemic effect in rats by cyclodextrin formulations.
Miro A; Quaglia F; Sorrentino U; La Rotonda MI; D'Emmanuele Di Villa Bianca R; Sorrentino R
Eur J Pharm Sci; 2004 Sep; 23(1):57-64. PubMed ID: 15324923
[TBL] [Abstract][Full Text] [Related]
39. Physicochemical characterization and pharmacokinetics evaluation of β-caryophyllene/β-cyclodextrin inclusion complex.
Liu H; Yang G; Tang Y; Cao D; Qi T; Qi Y; Fan G
Int J Pharm; 2013 Jun; 450(1-2):304-10. PubMed ID: 23598076
[TBL] [Abstract][Full Text] [Related]
40. Reduced hepatic toxicity, enhanced cellular uptake and altered pharmacokinetics of stavudine loaded galactosylated liposomes.
Garg M; Dutta T; Jain NK
Eur J Pharm Biopharm; 2007 Aug; 67(1):76-85. PubMed ID: 17303396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
